v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
StereoLabs
Common Stock
Common Stock
StereoLabs
Common Stock
Velodyne Merger
Additional Paid-in- Capital
Additional Paid-in- Capital
StereoLabs
Accumulated Deficit
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2024     52,560,770            
Beginning balance at Dec. 31, 2024 $ 180,911   $ 47     $ 1,094,938   $ (913,071) $ (1,003)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares)     13,558            
Issuance of common stock upon exercise of stock options 28         28      
Issuance of common stock in connection with Stereolabs acquisition/ Velodyne Merger (in shares)         164,394        
Issuance of common stock upon vesting of restricted stock units (in shares)     1,118,320            
Forfeited restricted stock awards (in shares)     (68,072)            
Common stock warrants issuable to customer 397         397      
Stock-based compensation expense 8,498         8,498      
Net loss (22,017)             (22,017)  
Other comprehensive (loss) income 126               126
Ending balance (in shares) at Mar. 31, 2025     53,788,970            
Ending balance at Mar. 31, 2025 167,943   $ 47     1,103,861   (935,088) (877)
Beginning balance (in shares) at Dec. 31, 2024     52,560,770            
Beginning balance at Dec. 31, 2024 180,911   $ 47     1,094,938   (913,071) (1,003)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (42,629)                
Ending balance (in shares) at Jun. 30, 2025     57,800,303            
Ending balance at Jun. 30, 2025 221,033   $ 47     1,177,232   (955,700) (546)
Beginning balance (in shares) at Mar. 31, 2025     53,788,970            
Beginning balance at Mar. 31, 2025 167,943   $ 47     1,103,861   (935,088) (877)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares)     12,497            
Issuance of common stock upon exercise of stock options 20         20      
Proceeds from at-the-market offering, net of commissions and fees and issuance costs (in shares)     3,522,177            
Proceeds from at-the-market offering, net of commissions and fees and issuance costs 58,521         58,521      
Issuance of common stock upon vesting of restricted stock units (in shares)     275,125            
Issuance of common stock to employees under employee stock purchase plan (in shares)     201,534            
Issuance of common stock to employees under employee stock purchase plan 980         980      
Common stock warrants issuable to customer 624         624      
Stock-based compensation expense 13,226         13,226      
Net loss (20,612)             (20,612)  
Other comprehensive (loss) income 331               331
Ending balance (in shares) at Jun. 30, 2025     57,800,303            
Ending balance at Jun. 30, 2025 $ 221,033   $ 47     1,177,232   (955,700) (546)
Beginning balance (in shares) at Dec. 31, 2025 60,947,757   60,947,757            
Beginning balance at Dec. 31, 2025 $ 261,738   $ 48     1,235,580   (973,448) (442)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares)     44,548            
Issuance of common stock upon exercise of stock options 94         94      
Issuance of common stock in connection with Stereolabs acquisition/ Velodyne Merger (in shares)       1,847,677          
Issuance of common stock in connection with Stereolabs acquisition   $ 22,779         $ 22,779    
Issuance of common stock upon vesting of restricted stock units (in shares)     621,109            
Common stock warrants issuable to customer 1,101         1,101      
Stock-based compensation expense 7,494         7,494      
Net loss (17,465)             (17,465)  
Other comprehensive (loss) income (120)               (120)
Ending balance (in shares) at Mar. 31, 2026     63,461,091            
Ending balance at Mar. 31, 2026 $ 275,621   $ 48     1,267,048   (990,913) (562)
Beginning balance (in shares) at Dec. 31, 2025 60,947,757   60,947,757            
Beginning balance at Dec. 31, 2025 $ 261,738   $ 48     1,235,580   (973,448) (442)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) 443,815                
Issuance of common stock to employees under employee stock purchase plan (in shares)     98,430            
Net loss $ (35,579)                
Ending balance (in shares) at Jun. 30, 2026 68,489,797   68,489,797            
Ending balance at Jun. 30, 2026 $ 371,308   $ 48     1,381,020   (1,009,027) (733)
Beginning balance (in shares) at Mar. 31, 2026     63,461,091            
Beginning balance at Mar. 31, 2026 275,621   $ 48     1,267,048   (990,913) (562)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares)     399,267            
Issuance of common stock upon exercise of stock options 2,248         2,248      
Proceeds from at-the-market offering, net of commissions and fees and issuance costs (in shares)     3,649,000            
Proceeds from at-the-market offering, net of commissions and fees and issuance costs 97,733         97,733      
Issuance of common stock upon vesting of restricted stock units (in shares)     882,009            
Issuance of common stock to employees under employee stock purchase plan (in shares)     98,430            
Issuance of common stock to employees under employee stock purchase plan 1,332         1,332      
Common stock warrants issuable to customer 1,274         1,274      
Stock-based compensation expense 11,385         11,385      
Net loss (18,114)             (18,114)  
Other comprehensive (loss) income $ (171)               (171)
Ending balance (in shares) at Jun. 30, 2026 68,489,797   68,489,797            
Ending balance at Jun. 30, 2026 $ 371,308   $ 48     $ 1,381,020   $ (1,009,027) $ (733)